https://www.selleckchem.com/pr....oducts/gsk650394.htm
ate of patients with the tumor regression grades 0, 1, 2 and 3 was 81.8%, 70.0%, 44.4%, and 20.0%, repectively (P=0.024); the 3-year OS rate was 81.8%, 75.0%, 48.1% and 40.0%, repectively (P=0.048). Conclusion nCRT improves treatment efficacy of Siewert type II and III AEG patients, and the long-term prognosis is good.Gastrointestinal cancer and related treatments (surgery and chemoradiotherapy) are associated with declined functional status (FS) that has impact on quality of life, clinical outcome and continuum of care. Psychological
Like
Comment
Share
